western blotting. Unlike current available vaccines in which some allergic reactions are observed, our chimer protein is continual and safe, stimulating both cellular and humoral immunity systems. Our construct could
native recombinant toxins that may serve as vaccine candidates. Here, we describe a novel chimeric toxin vaccine that retains major neutralizing epitopes from both toxins and confers complete protection against ... most…
that uses furthermore, improves the ordinary limit of the patient's resistant malignancy. Strategies: Chimeric Antigen Receptor (CAR) T-cell treatment includes Genetic modification of patient's autologous T-cells
Patients with relapsed or refractory Non-Hodgkin lymphoma (NHL) make sure a dismal prediction. Chimeric antigen receptor (CAR) modified T cells targeting CD20 have shown activity in clinical test phase
showed that Y chromosome CNV attribute to the normal female phenotype of 46XX/46XY chimerism. Discussion and Conclusions: The case presented here further describe a novel, fast target-next generation
recognized by a patient’s own T-cells through the expression of chimeric antigen receptors (CARs). These CAR-T cells represent the latest product of adoptive cellular immunotherapy
schistosomiasis endemic areas revealed IgG recognition of chimeras A and B. In conclusion, the chimeric proteins tested here induced superior protection against infection compared to Sm29 alone and higher levels
distinction between naturally infected and vaccineexposed animals is made possible by the use of chimeric antigens. In this study, chimeric fusion proteins derived from the multimerizing subunit of the mouse
cellular and tissue level grossly and can be classified as a macro chimerism. The fetus during the time of pregnancy also takes part in microchimerism through fetomaternal cell trafficking where ... fetal cells through…
Designer T cells are T lymphocytes engineered toward specific antibody-type membrane antigens through chimeric antigen receptor (CAR) and are mainly used for adoptive cellular immunotherapy. The designer ... tumor…
immunogenic sites of surface pneumococcal proteins could be an advantageous vaccine alternative. Methods: A chimeric recombinant protein named PSPF was constructed from conservative and immunogenic fragments of S…
There is no licensed RSV vaccine. Here, we generated recombinant influenza viruses carrying the chimeric constructs of hemagglutinin (HA) and central conserved-domains of the RSV G protein ... neutralizing epitopes…
Patients with relapsed or refractory Non-Hodgkin lymphoma (NHL) have a dismal prognosis. Chimeric antigen receptor (CAR) modified T cells targeting CD20 have shown activity in phase I clinical trial
recipients. Our results demonstrate the robust efficacy of this approach to establish mixed hematopoietic chimerism under nonmyeloablative conditioning and without complication of GVHD
analgesia, role in opioid modulation and tolerance development. Based on these reports a dualsteric chimeric peptide NPYFa (YGGFMKKKPQRFamide) was designed, having Met-enkephalin (opioid) and PQRF sequence of NPFF
double chimeric peptide vaccine, targeting two peptides (Fba and Met6) expressed on the cell surface of Candida albicans, can induce high degree of protection against disseminated candidiasis in mice. Although…
native recombinant toxins that may serve as vaccine candidates. Here we describe a novel chimeric toxin vaccine that retains major neutralizing epitopes from both toxins and confers complete protection against ... most…
exons only 14 (2.6%) of them were translated into protein, which we characterized as chimeric genes. From these chimeric genes, only the FAST kinase domains 3 (FASTKD3) gene, present
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.